This website is intended for Healthcare Professionals. If you are a patient seeking information you should consult your doctor or nurse. If you are involved in the purchase, supply or prescribing of medicines and / or pharmaceuticals please confirm below to learn more about Flexipharm Austrading and what we can offer.
I confirm I am a healthcare professional
Press Releases
Listed below are recent press releases. We only issue press releases for information that is relevant to our NHS customers. We do not Facebook, Instagram or Snapchat because we take what we do, supplying critical care medicines to the NHS, seriously. You cannot “follow us” or get “LinkedIn" to us (but you can call or email us and we will talk to you or call you back really quickly).
Press Release - November 2021 Phebra acquires equity stake in UK specialty hospital pharma company Flexipharm Austrading
Press Release - September 2020 Flexipharm Austrading announces protective vial sleeve to enhance user safety and performance of lead product, Arsenic Trioxide Phebra
Press Release - March 2020 Flexipharm Austrading announces launch of first vial and first generic presentation of Methylthioninium Chloride Improved presentation and lower price than alternative product for NHS hospitals
Press Release - March 2020 Flexipharm Austrading announces product update on Arsenic Trioxide Phebra Extension to in-use stability time
Press Release - August 2019 Arsenic Trioxide Phebra included in the framework agreement for NHS National Pharmaceuticals Transition 2019_1. Offer reference number: CM/PHG/17/5547
Press Release - May 2019 Flexipharm Austrading announces launch of Arsenic Trioxide Phebra (arsenic trioxide 1mg/ml concentrate for solution for infusion) Secure supply and first vial presentation of a pivotal drug for acute promyelocytic leukaemia
Presentations
Listed below is a company overview. Please contact us if you need further information.
